Inventors:
TOMAS GANZ - LOS ANGELES CA, US
LAN LIN - BEIJING, CN
YIGAL P. GOLDBERG - VANCOUVER, CA
International Classification:
A61K 38/17, C07K 14/435, G01N 33/68, C12N 15/63, C12N 5/07, A61P 3/00, A61P 3/02
US Classification:
514 212, 530350, 436 86, 4353201, 435325
Abstract:
Disclosed herein are hemojuvelin-specific siRNAs that vary hemojuvelin mRNA concentration. Also disclosed herein, GPI-hemojuvelin positively regulated hepcidin mRNA expression, independently of the IL-6 pathway, whereas soluble hemojuvelin (s-hemojuvelin) suppressed hepcidin mRNA expression in primary human hepatocytes in a log-linear dosedependent manner. Disclosed are compositions and methods for modulating diseases of iron metabolism and hepcidin expression or hepcidin levels.